Imolamine

This classification denotes a vasodilating agent with the molecular formula C14H20N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier K5F4RU5VQJ, chemically known as 4-(2-(diethylamino)ethyl)-5-imino-3-phenyl-delta(sup 2)-1,2,4-oxadiazoline but generally known as imolamine, which bears US NIH Compound Identifier 27501. European Medicines Agency schedules Imolamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08156MIG. The term IMOLAMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules imolamine in its Anatomical Therapeutic Chemical (ATC) Classification. IMOLAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule imolamine under HS 29349990 and SITC 51579. As of Q4 2014, IMOLAMINE remains the US FDA Preferred Term for this commodity. Imolamine bears US NLM identifiers UMLS ID C0063433 and NCI Concept Code C65899. SMILES: o1nc(n(CCN(CC)CC)c1=N)c1ccccc1.